If you build it, they will come: unintended future uses of organised health data collections
Open Access
- 6 September 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Medical Ethics
- Vol. 17 (1), 1-16
- https://doi.org/10.1186/s12910-016-0137-x
Abstract
Health research increasingly relies on organized collections of health data and biological samples. There are many types of sample and data collections that are used for health research, though these are collected for many purposes, not all of which are health-related. These collections exist under different jurisdictional and regulatory arrangements and include: Ethical, legal, and social challenges of such collections are well recognized, but there has been limited attention to the broader societal implications of the existence of these collections. Although health research conducted using these collections is broadly recognized as beneficent, secondary uses of these data and samples may be controversial. We examine both documented and hypothetical scenarios of secondary uses of health data and samples. In particular, we focus on the use of health data for purposes of: Current safeguards relating to the use of health data and samples include research ethics oversight and privacy laws. These safeguards have a strong focus on informed consent and anonymization, which are aimed at the protection of the individual research subject. They are not intended to address broader societal implications of health data and sample collections. As such, existing arrangements are insufficient to protect against subversion of health databases for non-sanctioned secondary uses, or to provide guidance for reasonable but controversial secondary uses. We are concerned that existing debate in the scholarly literature and beyond has not sufficiently recognized the secondary data uses we outline in this paper. Our main purpose, therefore, is to raise awareness of the potential for unforeseen and unintended consequences, in particular negative consequences, of the increased availability and development of health data collections for research, by providing a comprehensive review of documented and hypothetical non-health research uses of such data.Funding Information
- The Research Council of Norway (BIOTEK2021/238999)
- Canadian Institutes of Health Research (CA)
This publication has 99 references indexed in Scilit:
- Mobile phone health apps for diabetes management: Current evidence and future developmentsQJM: An International Journal of Medicine, 2013
- Strategies for De-identification and Anonymization of Electronic Health Record Data for Use in Multicenter Research StudiesMedical Care, 2012
- Biobank participation and returning research results: Perspectives from a deliberative engagement in South Side ChicagoAmerican Journal of Medical Genetics Part A, 2012
- Realizing the promise of population biobanks: a new model for translationHuman Genetics, 2011
- Ethical and practical challenges of sharing data from genome-wide association studies: The eMERGE Consortium experienceGenome Research, 2011
- Expectations, validity, and reality in pharmacogeneticsJournal of Clinical Epidemiology, 2010
- Is Deidentification Sufficient to Protect Health Privacy in Research?American Journal of Bioethics, 2010
- Genomic research and wide data sharing: Views of prospective participantsGenetics in Medicine, 2010
- Predicting Social Security numbers from public dataProceedings of the National Academy of Sciences of the United States of America, 2009
- Consent and anonymization in research involving biobanksEMBO Reports, 2006